Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Demandes d’études post-inscription (EPI), suivi des patients en vie réelle : évolution de la place des bases de données.
Berdaï D, Thomas-Delecourt F, Szwarcensztein K; table ronde « recherche clinique et méthodologie » des Ateliers de Giens XXXIII; d'Andon A, Collignon C, Comet D, Déal C, Dervaux B, Gaudin AF, Lamarque-Garnier V, Lechat P, Marque S, Maugendre P, Méchin H, Moore N, Nachbaur G, Robain M, Roussel C, Tanti A, Thiessard F. Berdaï D, et al. Among authors: marque s. Therapie. 2018 Feb;73(1):1-12. doi: 10.1016/j.therap.2017.12.001. Epub 2017 Dec 12. Therapie. 2018. PMID: 29499906 French. No abstract available.
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases.
Berdaï D, Thomas-Delecourt F, Szwarcensztein K, d'Andon A, Collignon C, Comet D, Déal C, Dervaux B, Gaudin AF, Lamarque-Garnier V, Lechat P, Marque S, Maugendre P, Méchin H, Moore N, Nachbaur G, Robain M, Roussel C, Tanti A, Thiessard F. Berdaï D, et al. Among authors: marque s. Therapie. 2018 Feb;73(1):13-24. doi: 10.1016/j.therap.2017.12.008. Epub 2017 Dec 30. Therapie. 2018. PMID: 29530314
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
Nasser M, Larrieu S, Boussel L, Si-Mohamed S, Bazin F, Marque S, Massol J, Thivolet-Bejui F, Chalabreysse L, Maucort-Boulch D, Hachulla E, Jouneau S, Le Lay K, Cottin V. Nasser M, et al. Among authors: marque s. Respir Res. 2021 May 24;22(1):162. doi: 10.1186/s12931-021-01749-1. Respir Res. 2021. PMID: 34030695 Free PMC article.
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study).
Nasser M, Larrieu S, Si-Mohamed S, Ahmad K, Boussel L, Brevet M, Chalabreysse L, Fabre C, Marque S, Revel D, Thivolet-Bejui F, Traclet J, Zeghmar S, Maucort-Boulch D, Cottin V. Nasser M, et al. Among authors: marque s. Eur Respir J. 2021 Feb 11;57(2):2002718. doi: 10.1183/13993003.02718-2020. Print 2021 Feb. Eur Respir J. 2021. PMID: 32943410 Free PMC article.
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France.
Cottin V, Larrieu S, Boussel L, Si-Mohamed S, Bazin F, Marque S, Massol J, Thivolet-Bejui F, Chalabreysse L, Maucort-Boulch D, Jouneau S, Hachulla E, Chollet J, Nasser M. Cottin V, et al. Among authors: marque s. Front Med (Lausanne). 2021 Aug 30;8:699532. doi: 10.3389/fmed.2021.699532. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34552943 Free PMC article.
178 results